ELIXIRGEN THERAPEUTICS, INC.

New Filing
CIK: 0001744333·Biotechnology·DELAWARE·Filed: Sep 29, 2022
Total Offering

$5,000,000

Amount Sold

$5,000,000

Investors

1

First Sale

Sep 14, 2022

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
AKIHIRO KO
Related Person
MINORU KO
Related Person
Maiko Katadae
Related Person
HIROAKI KOBAYASHI
Related Person
SHAUNA CALLAHAN
Related Person
THOMAS WHITE
Related Person

Company

ELIXIRGEN THERAPEUTICS, INC.

855 N. Wolfe Street, Suite 624

Baltimore, MD, 21205

443-451-5300

SEC Filing

0001744333-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
ELIXIRGEN THERAPEUTICS, INC. Form D Filing — $5,000,000 | FilingFlow